These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Evaluation of genotype MTBDRplus VER 2.0 line probe assay for the detection of MDR-TB in smear positive and negative sputum samples. Meaza A, Kebede A, Yaregal Z, Dagne Z, Moga S, Yenew B, Diriba G, Molalign H, Tadesse M, Adisse D, Getahun M, Desta K. BMC Infect Dis; 2017 Apr 17; 17(1):280. PubMed ID: 28415989 [Abstract] [Full Text] [Related]
7. Evaluation of the MTBDRplus 2.0 assay for the detection of multidrug resistance among persons with presumptive pulmonary TB in China. Tan Y, Li Q, Wang Q, Sun H, Chen J, Cai X, Yao Y, Bao X, Wang C, Liu Y, Wu X, Pang Y, Zhao Y. Sci Rep; 2017 Jun 13; 7(1):3364. PubMed ID: 28611407 [Abstract] [Full Text] [Related]
10. Use of GenoType® MTBDRplus assay to assess drug resistance and mutation patterns of multidrug-resistant tuberculosis isolates in northern India. Maurya AK, Singh AK, Kant S, Umrao J, Kumar M, Kushwaha RA, Nag VL, Dhole TN. Indian J Med Microbiol; 2013 Jun 13; 31(3):230-6. PubMed ID: 23883707 [Abstract] [Full Text] [Related]
11. Evaluation of GenoType® MTBDRplus assay for rapid detection of drug susceptibility testing of multi-drug resistance tuberculosis in Northern India. Maurya AK, Umrao J, Singh AK, Kant S, Kushwaha RA, Dhole TN. Indian J Pathol Microbiol; 2013 Jun 13; 56(2):139-43. PubMed ID: 24056651 [Abstract] [Full Text] [Related]
12. Detecting mutation pattern of drug-resistant Mycobacterium tuberculosis isolates in Himachal Pradesh using GenoType(®) MTBDRplus assay. Thakur C, Kumar V, Gupta AK. Indian J Med Microbiol; 2015 Jun 13; 33(4):547-53. PubMed ID: 26470962 [Abstract] [Full Text] [Related]
13. Evaluation of the GenoType® MTBDRplus assay and identification of a rare mutation for improving MDR-TB detection. Jin J, Zhang Y, Fan X, Diao N, Shao L, Wang F, Hu P, Wang S, Weng X, Zhang W. Int J Tuberc Lung Dis; 2012 Apr 13; 16(4):521-6. PubMed ID: 22325117 [Abstract] [Full Text] [Related]
14. Early results of systematic drug susceptibility testing in pulmonary tuberculosis retreatment cases in Cameroon. Noeske J, Voelz N, Fon E, Abena Foe JL. BMC Res Notes; 2012 Mar 21; 5():160. PubMed ID: 22436423 [Abstract] [Full Text] [Related]
15. Utility of Second-Generation Line Probe Assay (Hain MTBDRplus) Directly on 2-Month Sputum Specimens for Monitoring Tuberculosis Treatment Response. Rockwood N, Wojno J, Ghebrekristos Y, Nicol MP, Meintjes G, Wilkinson RJ. J Clin Microbiol; 2017 May 21; 55(5):1508-1515. PubMed ID: 28249999 [Abstract] [Full Text] [Related]
16. Tuberculosis drug resistance and outcomes among tuberculosis inpatients in Lilongwe, Malawi. Vorkas C, Kayira D, van der Horst C, Hoffman I, Hosseinipour M, Kanyemba C, Nguluwe N, Chikaonda T, Kalikhoka M, Kalaundi D, Namarika D, Gilligan P, Krysiak R. Malawi Med J; 2012 Jun 21; 24(2):21-4. PubMed ID: 23638265 [Abstract] [Full Text] [Related]